论文部分内容阅读
目的:探讨分析尿毒症性周围神经病变治疗中左卡尼汀联合血液透析的应用效果。方法:选取我院收治的尿毒症性周围神经病变患者80例作为观察对象,将其随机分为观察组和对照组,各40例。对照组采用常规血液透析治疗,观察组采用左卡尼汀联合血液透析治疗。观察分析两组患者治疗前后2个月周围神经病变的临床症状变化情况。结果:经过治疗后,观察组患者的感觉障碍、肢端疼痛、不宁腿综合症以及麻木感等临床症状明显优于对照组,两组之间的比较有显著差异(p<0.05),具有统计学意义。结论:左卡尼汀联合血液透析治疗尿毒症性周围神经病变,具有显著的治疗效果,能有效改善患者的疾病临床症状,值得在临床治疗中推广运用。
Objective: To investigate the application of levocarnitine and hemodialysis in the treatment of uremic peripheral neuropathy. Methods: Totally 80 cases of uremic peripheral neuropathy admitted to our hospital were selected as observation objects and randomly divided into observation group and control group, 40 cases each. The control group was treated with routine hemodialysis. The observation group was treated with levocarnitine and hemodialysis. Observation and analysis of two groups of patients before and after treatment for 2 months, the clinical symptoms of peripheral neuropathy changes. Results: After treatment, the clinical symptoms such as sensory disturbances, acral pain, restless legs syndrome and numbness in the observation group were significantly better than those in the control group. There was significant difference between the two groups (p <0.05) Statistical significance. Conclusion: L-carnitine combined with hemodialysis treatment of uremic peripheral neuropathy, with significant therapeutic effect, can effectively improve the clinical symptoms of the disease, it is worth to promote the use of clinical treatment.